— Exosomes dérivés de cellules souches
VisioLife is intended for the diagnostic or laboratory workflow described by VisioLife in its controlled catalog identity and is classified under the Advanced biotechnology method at portfolio level. Exact intended-use boundaries must be confirmed from the current product-specific IFU. VisioLife is listed under REF VisioLife in the Stem-Cell-Derived Exosomes portfolio. The catalog pack or reaction format is Stem-cell-derived exosome platform product. Request controlled technical documentation for composition and permitted-use information.. Catalog note: /exosomes/visiolife.jpg Confirm the current product-specific IFU, regulatory status and country availability before ordering or clinical use.